1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. E-therapeutics plc
  6. Summary
    ETX   GB00B2823H99

E-THERAPEUTICS PLC

(ETX)
  Report
Delayed London Stock Exchange  -  05/20 11:35:09 am EDT
19.48 GBX   -3.11%
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Revenue GBP477,000
MT
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Loss GBX-1.65
MT
05/04E-therapeutics plc Announces Change of Registered Office
CI
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
23.25(c) 22.8(c) 20.7(c) 20.1(c) 19.475(c) Last
92 282 609 126 271 463 731 59 205 Volume
-0.21% -1.94% -9.21% -2.90% -3.11% Change
More quotes
Estimated financial data (e)
More Financials
Company
e-Therapeutics Plc provides computer-based drug discovery platform. The Company's platform is a combination of databases and a suite of computational tools that employ network analysis, data mining, machine learning, artificial intelligence (Al) and optimization. Its in silico platform serves as a laboratory, which enables it to computationally test potential therapeutic interventions. Its network-driven drug... 
Sector
Biotechnology & Medical Research
Calendar
07/19 | 07:30amShareholder meeting
More about the company
All news about E-THERAPEUTICS PLC
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Revenue GBP477,000
MT
05/04Earnings Flash (ETX.L) E-THERAPEUTICS Posts FY22 Loss GBX-1.65
MT
05/04E-therapeutics plc Announces Change of Registered Office
CI
05/04E-therapeutics plc Reports Earnings Results for the Full Year Ended January 31, 2022
CI
04/12E-therapeutics Achieves Key Milestones Under Collaboration with Galapagos
MT
04/05E-therapeutics Jumps 8% on Collaboration to Develop New Immuno-Oncology Therapies
MT
2021E-Therapeutics CFO to Step Down; Interim Finance Chief Named
MT
2021E-Therapeutics plc Announces Executive Changes
CI
2021Director Dealing – 26th October 2021
PU
2021E THERAPEUTICS : Interim Results, July 2021 and RNAi Platform Development Presentation
PU
2021E THERAPEUTICS : Interim results for six months ended 31 July 2021
PU
2021E THERAPEUTICS : Earnings Flash (ETX.L) E-THERAPEUTICS Reports Fiscal H1 Loss GBX-0.54
MT
2021E THERAPEUTICS : Earnings Flash (ETX.L) E-THERAPEUTICS Reports Fiscal H1 Revenue GBP477,00..
MT
2021E THERAPEUTICS : RNAi Platform Characterisation Results
PU
2021E-therapeutics plc Reports Earnings Results for the Half Year Ended July 31, 2021
CI
More news
News in other languages on E-THERAPEUTICS PLC
05/04Earnings Flash (ETX.L) E-THERAPEUTICS affiche un revenu de 477 000 GBP pour l'exercice ..
05/04E-therapeutics plc publie ses résultats financiers pour l'exercice complet clos le 31 j..
04/12E-therapeutics franchit les étapes clés de sa collaboration avec Galapagos
04/05E-therapeutics bondit de 8% grâce à une collaboration visant à développer de nouvelles ..
2021Le directeur financier d'E-Therapeutics quitte ses fonctions ; un directeur financier i..
More news
Chart E-THERAPEUTICS PLC
Duration : Period :
e-therapeutics plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends E-THERAPEUTICS PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Ahmad Ali Mortazavi Chief Executive Officer & Director
Michael Anthony Bretherton Chief Financial Officer & Director
Trevor Mervyn Jones Independent Non-Executive Chairman
Alan Whitmore Chief Scientific Officer
Jonny Wray Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
E-THERAPEUTICS PLC-56.04%125
MODERNA, INC.-46.35%54 195
LONZA GROUP AG-27.84%41 796
IQVIA HOLDINGS INC.-28.46%38 202
SEAGEN INC.-9.68%25 704
ICON PUBLIC LIMITED COMPANY-30.22%17 567